Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

1.

Aggressive surgery for metastatic liver neuroendocrine tumors.

Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT.

Surgery. 2003 Dec;134(6):1057-63; discussion 1063-5.

PMID:
14668741
[PubMed - indexed for MEDLINE]
2.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
[PubMed - indexed for MEDLINE]
3.

Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.

Eriksson J, Stålberg P, Nilsson A, Krause J, Lundberg C, Skogseid B, Granberg D, Eriksson B, Akerström G, Hellman P.

World J Surg. 2008 May;32(5):930-8. doi: 10.1007/s00268-008-9510-3.

PMID:
18324347
[PubMed - indexed for MEDLINE]
4.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
[PubMed - indexed for MEDLINE]
5.

Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.

Norton JA.

Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):577-83. Review.

PMID:
16183528
[PubMed - indexed for MEDLINE]
6.

[Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].

Kianmanesh R, O'toole D, Sauvanet A, Ruszniewski P, Belghiti J.

J Chir (Paris). 2005 May-Jun;142(3):132-49. Review. French.

PMID:
16142076
[PubMed - indexed for MEDLINE]
7.

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.

Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, Benson AB, Rao S, Joehl RJ.

Surgery. 2001 Oct;130(4):677-82; discussion 682-5.

PMID:
11602899
[PubMed - indexed for MEDLINE]
8.

Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years.

Nave H, Mössinger E, Feist H, Lang H, Raab H.

Surgery. 2001 Feb;129(2):170-5.

PMID:
11174710
[PubMed - indexed for MEDLINE]
9.

Hepatic resection for metastatic neuroendocrine carcinomas.

Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK.

Am J Surg. 1995 Jan;169(1):36-42; discussion 42-3.

PMID:
7817996
[PubMed - indexed for MEDLINE]
10.

Resection of malignant primary liver tumors.

Holbrook RF, Koo K, Ryan JA.

Am J Surg. 1996 May;171(5):453-5.

PMID:
8651382
[PubMed - indexed for MEDLINE]
11.

Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.

Mazzaglia PJ, Berber E, Milas M, Siperstein AE.

Surgery. 2007 Jul;142(1):10-9.

PMID:
17629995
[PubMed - indexed for MEDLINE]
12.

Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.

Gillams A, Cassoni A, Conway G, Lees W.

Abdom Imaging. 2005 Jul-Aug;30(4):435-41.

PMID:
15759207
[PubMed - indexed for MEDLINE]
13.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278
[PubMed - indexed for MEDLINE]
14.

Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.

Elias D, Goéré D, Leroux G, Dromain C, Leboulleux S, de Baere T, Ducreux M, Baudin E.

Eur J Surg Oncol. 2009 Oct;35(10):1092-7. doi: 10.1016/j.ejso.2009.02.017. Epub 2009 May 21.

PMID:
19464140
[PubMed - indexed for MEDLINE]
15.

Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.

Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W, Meyer T.

Ann Surg Oncol. 2005 Oct;12(10):778-85. Epub 2005 Aug 18.

PMID:
16132374
[PubMed - indexed for MEDLINE]
16.

Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.

Grazi GL, Cescon M, Pierangeli F, Ercolani G, Gardini A, Cavallari A, Mazziotti A.

Hepatogastroenterology. 2000 Mar-Apr;47(32):481-6.

PMID:
10791218
[PubMed - indexed for MEDLINE]
17.

Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.

Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA.

Arch Surg. 2006 Jun;141(6):537-43; discussion 543-4.

PMID:
16785353
[PubMed - indexed for MEDLINE]
18.

[Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].

Fendrich V, Habbe N, Celik I, Langer P, Zielke A, Bartsch DK, Rothmund M.

Dtsch Med Wochenschr. 2007 Feb 2;132(5):195-200. German.

PMID:
17252361
[PubMed - indexed for MEDLINE]
19.

The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.

Chambers AJ, Pasieka JL, Dixon E, Rorstad O.

Surgery. 2008 Oct;144(4):645-51; discussion 651-3. doi: 10.1016/j.surg.2008.06.008.

PMID:
18847650
[PubMed - indexed for MEDLINE]
20.

Aggressive surgery for liver metastases from gastrointestinal stromal tumors.

Shima Y, Horimi T, Ishikawa T, Ichikawa J, Okabayashi T, Nishioka Y, Hamada M, Shibuya Y, Ishii T, Ito M.

J Hepatobiliary Pancreat Surg. 2003;10(1):77-80.

PMID:
12827476
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk